Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis
Objective To review the evidence on the effectiveness of public health measures in reducing
the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality. Design …
the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality. Design …
The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review
I Mohammed, A Nauman, P Paul… - Human vaccines & …, 2022 - Taylor & Francis
With the relatively rapid development of the COVID-19 pandemic, vaccine development has
become crucial for limiting disease transmission. The accelerated growth in the approved …
become crucial for limiting disease transmission. The accelerated growth in the approved …
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
M Sadarangani, A Marchant… - Nature Reviews …, 2021 - nature.com
Most COVID-19 vaccines are designed to elicit immune responses, ideally neutralizing
antibodies (NAbs), against the SARS-CoV-2 spike protein. Several vaccines, including …
antibodies (NAbs), against the SARS-CoV-2 spike protein. Several vaccines, including …
[HTML][HTML] Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Summary Background The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca
(ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase …
(ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase …
[HTML][HTML] Ten scientific reasons in support of airborne transmission of SARS-CoV-2
Ten scientific reasons in support of airborne transmission of SARS-CoV-2 - The Lancet Skip to
Main Content Advertisement The Lancet Journal This Journal Back Journal Home Online First …
Main Content Advertisement The Lancet Journal This Journal Back Journal Home Online First …
Effect of vaccination on household transmission of SARS-CoV-2 in England
RJ Harris, JA Hall, A Zaidi, NJ Andrews… - … England Journal of …, 2021 - Mass Medical Soc
Vaccination and Household Transmission of SARS-CoV-2 In this study involving household
contacts of persons with laboratory-confirmed Covid-19, the risk of household transmission …
contacts of persons with laboratory-confirmed Covid-19, the risk of household transmission …
[HTML][HTML] Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
Summary Background The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19
(Oxford–AstraZeneca) COVID-19 vaccines have shown high efficacy against disease in …
(Oxford–AstraZeneca) COVID-19 vaccines have shown high efficacy against disease in …
[HTML][HTML] Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised …
Background A new variant of SARS-CoV-2, B. 1.1. 7, emerged as the dominant cause of
COVID-19 disease in the UK from November, 2020. We report a post-hoc analysis of the …
COVID-19 disease in the UK from November, 2020. We report a post-hoc analysis of the …
[HTML][HTML] BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health …
Y Lustig, E Sapir, G Regev-Yochay… - The Lancet …, 2021 - thelancet.com
Summary Background Concurrent with the Pfizer–BioNTech BNT162b2 COVID-19 vaccine
roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and …
roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and …
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test …
H Chung, S He, S Nasreen, ME Sundaram, SA Buchan… - bmj, 2021 - bmj.com
Objective To estimate the effectiveness of mRNA covid-19 vaccines against symptomatic
infection and severe outcomes (hospital admission or death). Design Test negative design …
infection and severe outcomes (hospital admission or death). Design Test negative design …